Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Fuchs

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|July 15, 2024
PRDM16-DT: A Brain and Astrocyte-Specific lncRNA Implicated in Alzheimer's DiseaseSophie Schröder, Ulrike Fuchs, Verena Gisa, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Loss of the lncRNA <i>SOX1-OT</i> promotes p53-dependent cell-cycle arrest in astrocytesUlrike Fuchs, Sophie Schröder, Tonatiuh Pena, et al.
Journal of Travel Medicine|December 13, 2023
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults†Robert McMahon, Ulrike Fuchs, Martina Schneider, et al.
The Journal of Biological Chemistry|September 2, 2020
Receptor-independent modulation of cAMP-dependent protein kinase and protein phosphatase signaling in cardiac myocytes by oxidizing agentsSimon Diering, Konstantina Stathopoulou, Mara Goetz, et al.
Lancet (London, England)|June 15, 2023
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trialMartina Schneider, Marivic Narciso-Abraham, Sandra Hadl, et al.
Nature Medicine|February 6, 2026
Live-attenuated chikungunya vaccine in children: a randomized phase 2 trialPetronela Weisová, Susanne Scheiblauer, Jacqueline Ecker, et al.
JACC. Basic to Translational Science|January 16, 2026
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability To Cause AortopathyMarie E Jost, Moyra Schweizer, Philipp Henning, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|July 15, 2024
PRDM16-DT: A Brain and Astrocyte-Specific lncRNA Implicated in Alzheimer's DiseaseSophie Schröder, Ulrike Fuchs, Verena Gisa, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Loss of the lncRNA <i>SOX1-OT</i> promotes p53-dependent cell-cycle arrest in astrocytesUlrike Fuchs, Sophie Schröder, Tonatiuh Pena, et al.
Journal of Travel Medicine|December 13, 2023
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults†Robert McMahon, Ulrike Fuchs, Martina Schneider, et al.
The Journal of Biological Chemistry|September 2, 2020
Receptor-independent modulation of cAMP-dependent protein kinase and protein phosphatase signaling in cardiac myocytes by oxidizing agentsSimon Diering, Konstantina Stathopoulou, Mara Goetz, et al.
Lancet (London, England)|June 15, 2023
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trialMartina Schneider, Marivic Narciso-Abraham, Sandra Hadl, et al.
Nature Medicine|February 6, 2026
Live-attenuated chikungunya vaccine in children: a randomized phase 2 trialPetronela Weisová, Susanne Scheiblauer, Jacqueline Ecker, et al.
JACC. Basic to Translational Science|January 16, 2026
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability To Cause AortopathyMarie E Jost, Moyra Schweizer, Philipp Henning, et al.
Pageof 2